Pharmaceuticals & Life Sciences

Speeches & Presentations

• "Under the Watchful Eye of the FDA: What Do FDA Warning Letters Tell Us?" Third Annual ABA Life Sciences Legal Summit, San Francisco, CA (September 21, 2016). Presenter: John Fuson.
• "The Medicine, Science, and Liability Aspects of Traumatic Brain Injuries in Athletics,” 2016 West Coast Advisory Council, Newport Beach, CA (April 14, 2016). Presenter: Kevin C. Mayer.
• "Anatomy of a PTO PTAB Patent Trial in the Hatch-Waxman Arena," ACI - Paragraph IV Disputes Master Symposium, Chicago, IL (October 2, 2015). Presenter: Terry Rea.
• "Corporate Counsel Litigation Forum: Strategies & Trends in Effective Value-Based Billing," Crowell & Moring's Corporate Counsel Litigation Forum Webinar Series (June 23, 2015). Moderator: Jerome A. Murphy; Panelists: Robert A. Lipstein, Matthew Laws, Dr. Silvia Hodges Silverstein, and Justin Ergler.
• "Ethics Workshop - EGA Code of Conduct," 21st EGA Annual Conference, Berlin, Germany (June 10, 2015). Presenter: Christian Dekoninck.
• "Cooperating Safely with Competitors," International Chamber of Commerce UK Compliant Collaboration Workshop, London (May 27, 2015). Presenter: Sean-Paul Brankin.
• "Health Care Industry Emerging Legal Issues Webinar Series - Health Care Antitrust Update: Accountable, Coordinated, and Reformed, So What's New?" Crowell & Moring Webinar (May 13, 2015). Presenters: Arthur N. Lerner and Katherine I. Funk.
• "This Year in Trade - What's Ahead in 2015: Export Controls," Crowell & Moring Webinar (February 10, 2015). Presenters: Dr. Salomé Cisnal de Ugarte, Christopher Monahan, Maria Alejandra (Jana) del-Cerro, and David (Dj) Wolff.
• "Lessons Learned From the First IPRs and PGRs: Best Practices for Offensive and Defensive Use of AIA Procedures in the Life Sciences Space," Life Sciences Patents, ACI, New York, NY (January 13-14, 2015). Speaker: Terry Rea.
• "What are the Unforeseen Outcomes of a Rapidly-Changing Healthcare Landscape?" Unintended Consequences of Healthcare & Life Science Legislation Symposium, Washington, D.C. (October 15, 2014). Speaker: Terry Rea.
• "Timing is Everything: Managing the Logistics of the BPCIA Exchange Process and Preparing for "Early" and "Late" Phase Litigation," ACI - Biosimilars: The Definitive Forum on the Legal, Regulatory, Patent, and Commercial Realities of Biosimilars (June 6, 2014). Presenter: James K. Stronski.
• "The Most Powerful Tool in Your Arsenal: Using Inter-Partes Review at the PTO to Revamp Branded and Biosimilar Litigation Strategies," ACI - Biosimilars: The Definitive Forum on the Legal, Regulatory, Patent, and Commercial Realities of Biosimilars (June 6, 2014). Moderator: Terry Rea.
• "Interim and Cross-Border Injunctions Against Pharmaceutical Patent Infringement," ERA Annual Conference on EU Law in the Pharmaceutical Sector (February 27, 2014). Speaker: Jan-Diederik Lindemans.
• "Regulatory Considerations in the Medical Device Litigation Discovery Process," Exponent Webinar (November 12, 2013). Presenter: John Fuson.
• "Update on Court Cases that Affect the Industry," 9th EGA Legal Affairs Forum, Brussels, Belgium (March 19-20, 2013). Presenter: Kristof Roox.
• "Patent Settlement Agreements: A Generic Standpoint," SMi’s Generics, Supergenerics and Patent Strategies conference - London, UK (May 14-15, 2012). Speaker: Sean-Paul Brankin.
• "Disclosure of Prior Art and Forthcoming Antitrust Issues," C5's 4th Annual Conference on 'Pharma & Biotech Patent Litigation', Amsterdam (January 31 - February 1, 2012). Speaker: Sean-Paul Brankin.
• "Utilizing Applicable Valuation Models to Set Realistic Expectations for a Deal," American Conference Institute 15th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions, San Francisco (July 2011). Panelist: Jeffrey C. Selman.
• "A review of key cases affecting generic companies," 7th EGA Legal Affairs Forum, Brussels (March 17-18, 2011). Speaker: Kristof Roox.
• "Patent strategies towards generics," ERA Training of national judiciaries, Trier, Germany (February 17, 2011). Speaker: Sean-Paul Brankin.